Laser in Situ Keratomileusis
3 clinical trials · Condition
◉ Watch Laser in Situ Keratomileusis
| Record | Firm | Date |
|---|---|---|
| Patient Reported Outcomes With LASIK: PROWL-2 (NCT01655420) | Food and Drug Administration (FDA) | 2012-07-01 |
| Patient-Reported Outcomes With LASIK:PROWL-1 (NCT01526291) | Food and Drug Administration (FDA) | 2011-08-01 |
| Study of Cyclosporine in Post-LASIK Patients (NCT00991458) | Allergan | 2009-10-01 |
Track Laser in Situ Keratomileusis automatically
Every clearance here is in the API, with alerts when new ones post.